Evidence map›Paper›PMID 19151387›Full record

ArticleInvestigative ophthalmology & visual science2009

Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium.

Bobbie Ann Austin, Baoying Liu, Zhuqing Li, Robert B Nussenblatt

Open access · greenAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).International journal of molecular sciences · 2020
    Review
  10. SARI prevents ocular angiogenesis and inflammation in mice.Journal of cellular and molecular medicine · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Oxidative damage induces MCP-1 secretion and macrophage aggregation in age-related macular degeneration (AMD).Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bobbie Ann AustinNational Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-1857, USA. drbob@nei.nih.gov
Baoying Liu
Zhuqing Li
Robert B Nussenblatt
National Eye Institute · USNational Institutes of Health · US

Funding

Cellular and molecular mechanisms in Age Related Macular Degeneration & UveitisZIAEY000464 · NEI · NATIONAL EYE INSTITUTE · PI CHAIGNE-DELALANDE, BENJAMIN · 2009 to 2016
$2.4M
Treatment of choroidal subretinal neovascularization with immune agentsZ01EY000439 · NEI · NATIONAL EYE INSTITUTE · PI NUSSENBLATT, ROBERT B. · 2006 to 2008
$886k
Treatment of choroidal subretinal neovascularization with immune agentsZIAEY000439 · NEI · NATIONAL EYE INSTITUTE · PI NUSSENBLATT, ROBERT · 2009 to 2011
$640k
Intramural NIH HHS Z01 EY000439
6 · The paper itself

Abstract

purposeHigh-temperature requirement serine protease (HTRA1) was identified as a candidate age-related macular degeneration gene in multiple genetic studies in humans. To date, no functional studies have shown a mechanism for HTRA1 to instigate ocular tissue abnormalities. In the present study, the authors focused on a substrate of HTRA1, fibronectin, because fibronectin fragments (Fnfs) stimulate biochemical events in other age-related degenerative diseases that are analogous to changes associated with age-related macular degeneration (AMD). The purpose of the study was to determine whether Fnfs stimulate the release of proinflammatory and catabolic cytokines from murine retinal pigment epithelium (RPE).

methodsFibronectin was purified from murine serum by gelatin cross-linked agarose chromatography and subsequently was enzymatically digested with alpha-chymotrypsin. The bioactivity of Fnfs was verified by measuring levels of IL-6 and TNF-alpha in Fnf-exposed murine splenocytes. To analyze the effect of Fnfs on RPE, cytokine and chemokine levels in RPE culture supernatants were assayed by ELISA.

resultsIL-6 and TNF-alpha proinflammatory cytokines were released from primary murine splenocytes in proportion to the dose and length of Fnf treatment, indicating that alpha-chymotryptic digests of fibronectin are biologically active. Fnf treatment of murine RPE cells stimulated the release of microgram and nanogram levels of IL-6, MMP-3, MMP-9, and MCP-1, whereas only picogram levels were detected in untreated cells.

conclusionsFnfs stimulate the release of proinflammatory cytokines, matrix metalloproteinases, and monocyte chemoattractant protein from murine RPE cells. This observation indicated that Fnfs could contribute to ocular abnormalities by promoting inflammation, catabolism, and monocyte chemoattraction.

Indexed as

AnimalsCells, CulturedChemokine CCL2ChemokinesDose-Response Relationship, DrugElectrophoresis, Polyacrylamide GelEnzyme-Linked Immunosorbent AssayFibronectinsInterleukin-6Matrix Metalloproteinase 3Matrix Metalloproteinase 9MiceMice, Inbred C57BLPeptide FragmentsRetinal Pigment EpitheliumTime FactorsCcl2 protein, mouseChemokine CCL2ChemokinesFibronectinsInterleukin-6Matrix Metalloproteinase 3Matrix Metalloproteinase 9Peptide Fragments

Identifiers

PMID19151387
PMCPMC2754868
OpenAlexW2028541460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.